To update and integrate the recommendations for ankylosing spondylitis and the
recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial …

Background Biologics are used for the treatment of rheumatoid arthritis and many other
conditions. While the efficacy of biologics has been established, there is uncertainty …

Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-
EULAR recommendations for the management of axial spondyloarthritis (axSpA). Methods …

Background Non-infectious uveitis is a potentially sight-threatening ocular disorder caused
by chronic inflammation and its complications. Therapeutic success is limited by systemic …

Topic To provide recommendations for the use of anti-tumor necrosis factor α (TNF-α)
biologic agents in patients with ocular inflammatory disorders. Clinical Relevance Ocular …

Topic An international, expert-led consensus initiative to develop systematic, evidence-
based recommendations for the treatment of noninfectious uveitis in the era of biologics …

Background: Intravitreal injection (IVI) with administration of various pharmacological agents
is a mainstay of treatment in ophthalmology for endopthalmitis, viral retinitis, age-related …

Objective Population‐based studies of patients with ankylosing spondylitis indicate that
tumor necrosis factor (TNF) inhibitors prevent uveitis. Paradoxically, anecdotal reports …

Objective To investigate the safety and efficacy of etanercept in the treatment of uveitis
associated with juvenile idiopathic arthritis (JIA). Methods Children who met the American …

Behcet's disease (BD) is a multisystem, chronic-relapsing, inflammatory disorder classified
among the vasculitides [1, 2]. It has a worldwide distribution being more prevalent in the …